Cartesian TherapeuticsRNAC 
$18.47-4.55%24h
-4.55%24h
Global rank4175
Market cap$2.67B
Change 7d0.71%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Cartesian Therapeutics (RNAC)
As of January 2025, Cartesian Therapeutics has a market cap of $2.67B. This makes Cartesian Therapeutics the world's 4175th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Cartesian Therapeutics from 2016 to 2024
-
Value:-
Market cap history of Cartesian Therapeutics from 2016 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $110.36M | 10.65% |
| 2023 | $99.74M | -39.03% |
| 2022 | $163.58M | -65.34% |
| 2021 | $471.91M | 7.59% |
| 2020 | $438.62M | 27.31% |
| 2019 | $344.53M | -10.53% |
| 2018 | $385.06M | -72.88% |
| 2017 | $1.42B | -42.80% |
| 2016 | $2.48B | - |
RNAC Market Cap Today is $2.67B -4.55% - 25 Jan 2025
View largest stocks by market cap 
